Editas Medicine Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 9.35 M | $19.16 M | 16.55% | 10.38% |
| VANGUARD GROUP INC | 01/29/2026 | 8.21 M | $16.83 M | 17.84% | 9.11% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 3.04 M | $6.23 M | 137.97% | 3.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.28 M | $4.68 M | 11.99% | 2.54% |
| NUVEEN, LLC | 02/12/2026 | 1.98 M | $4.05 M | -5.49% | 2.19% |
| STATE STREET CORP | 02/13/2026 | 1.97 M | $4.05 M | 2.59% | 2.19% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.63 M | $3.35 M | 3.06% | 1.81% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 1.22 M | $2.51 M | 1.59% | 1.36% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 1.18 M | $2.43 M | 622.85% | 1.32% |
| JANE STREET GROUP, LLC | 02/12/2026 | 1.18 M | $2.41 M | 127.76% | 1.31% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.11 M | $2.27 M | 855.07% | 1.23% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 881.96 K | $1.81 M | 92.45% | 0.98% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/13/2026 | 827.14 K | $1.70 M | 3.39% | 0.92% |
| CITADEL ADVISORS LLC | 02/17/2026 | 820.99 K | $1.68 M | 126.67% | 0.91% |
| UBS GROUP AG | 01/29/2026 | 809.34 K | $1.66 M | 91.61% | 0.90% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 799.85 K | $1.64 M | 124.26% | 0.89% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 794.67 K | $1.63 M | 1.89% | 0.88% |
| JPMORGAN CHASE & CO | 02/11/2026 | 783.10 K | $1.61 M | -4.58% | 0.87% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 733.48 K | $1.50 M | 100.00% | 0.81% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 704.66 K | $1.44 M | -11.83% | 0.78% |
| MORGAN STANLEY | 02/13/2026 | 678.91 K | $1.39 M | -37.59% | 0.75% |
| NORTHERN TRUST CORP | 02/17/2026 | 662.46 K | $1.36 M | -1.08% | 0.74% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 644.20 K | $1.32 M | -6.33% | 0.72% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 568.81 K | $1.17 M | 100.00% | 0.63% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2026 | 562.14 K | $1.15 M | -0.62% | 0.62% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 372.10 K | $762.81 K | 180.62% | 0.41% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 335.48 K | $687.73 K | -64.00% | 0.37% |
| DIADEMA PARTNERS LP | 02/17/2026 | 318.70 K | $653.34 K | 6.23% | 0.35% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 290.92 K | $596.38 K | 100.00% | 0.32% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 01/14/2026 | 279.53 K | $573.05 K | 15.66% | 0.31% |
| BARCLAYS PLC | 02/13/2026 | 276.26 K | $566.34 K | 47.69% | 0.31% |
| XTX TOPCO LTD | 02/17/2026 | 246.61 K | $505.54 K | -5.19% | 0.27% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 245.34 K | $502.95 K | -7.31% | 0.27% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 02/17/2026 | 244.36 K | $500.93 K | -20.75% | 0.27% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 193.68 K | $397.03 K | -81.09% | 0.22% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 187.89 K | $385.18 K | -0.13% | 0.21% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/05/2026 | 181.59 K | $372.00 K | 1.79% | 0.20% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 167.53 K | $343.44 K | 0.00% | 0.19% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 162.74 K | $333.62 K | 26.83% | 0.18% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 162.33 K | $332.78 K | -51.66% | 0.18% |
| GREEN ALPHA ADVISORS, LLC | 01/07/2026 | 161.12 K | $330.30 K | 10.05% | 0.18% |
| FMR LLC | 02/17/2026 | 141.65 K | $290.39 K | 42.14% | 0.16% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 139.90 K | $286.80 K | 108.55% | 0.16% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 139.77 K | $286.53 K | -39.72% | 0.16% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 119.40 K | $244.76 K | -69.68% | 0.13% |
| WALLEYE TRADING LLC | 02/13/2026 | 117.10 K | $240.06 K | 1,851.67% | 0.13% |
| HSBC HOLDINGS PLC | 03/20/2026 | 112.19 K | $230.54 K | 16.98% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 109.70 K | $224.89 K | 72.76% | 0.12% |
| RHUMBLINE ADVISERS | 02/13/2026 | 109.31 K | $224.06 K | -10.79% | 0.12% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/17/2026 | 108.55 K | $222.52 K | 169.16% | 0.12% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Editas Medicine Inc institutional Ownership - FAQ's
During the previous two years, 297 institutional investors and hedge funds held shares of Editas Medicine Inc. The most heavily invested institutionals were:
Nuveen, LLC: 1.98 M
VANGUARD FIDUCIARY TRUST CO: 614,036
GSA CAPITAL PARTNERS LLP: 434,413
UBS Group AG: 393,754
Bank of New York Mellon Corp: 272,567
Cambridge Investment Research Advisors, Inc.: 178,483
55.43% of Editas Medicine Inc stock is owned by institutional investors.
Institutional investors have bought a total of 69.67 M shares in the last 24 months. This purchase volume represents approximately $161.63 M in transactions.